These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 28767041

  • 1. Multifunctional halloysite nanotubes for targeted delivery and controlled release of doxorubicin in-vitro and in-vivo studies.
    Hu Y, Chen J, Li X, Sun Y, Huang S, Li Y, Liu H, Xu J, Zhong S.
    Nanotechnology; 2017 Sep 15; 28(37):375101. PubMed ID: 28767041
    [Abstract] [Full Text] [Related]

  • 2. Enhanced antitumor efficacy of doxorubicin-encapsulated halloysite nanotubes.
    Li K, Zhang Y, Chen M, Hu Y, Jiang W, Zhou L, Li S, Xu M, Zhao Q, Wan R.
    Int J Nanomedicine; 2018 Sep 15; 13():19-30. PubMed ID: 29296083
    [Abstract] [Full Text] [Related]

  • 3. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
    Zhang L, Qin Y, Zhang Z, Fan F, Huang C, Lu L, Wang H, Jin X, Zhao H, Kong D, Wang C, Sun H, Leng X, Zhu D.
    Acta Biomater; 2018 Jul 15; 75():371-385. PubMed ID: 29777957
    [Abstract] [Full Text] [Related]

  • 4. Legumain-cleavable 4-arm poly(ethylene glycol)-doxorubicin conjugate for tumor specific delivery and release.
    Zhou H, Sun H, Lv S, Zhang D, Zhang X, Tang Z, Chen X.
    Acta Biomater; 2017 May 15; 54():227-238. PubMed ID: 28315495
    [Abstract] [Full Text] [Related]

  • 5. Enhanced Therapeutic Efficacy of Doxorubicin for Breast Cancer Using Chitosan Oligosaccharide-Modified Halloysite Nanotubes.
    Yang J, Wu Y, Shen Y, Zhou C, Li YF, He RR, Liu M.
    ACS Appl Mater Interfaces; 2016 Oct 12; 8(40):26578-26590. PubMed ID: 27628202
    [Abstract] [Full Text] [Related]

  • 6. Assembling of stimuli-responsive tumor targeting polypyrrole nanotubes drug carrier system for controlled release.
    Chen J, Li X, Li J, Li J, Huang L, Ren T, Yang X, Zhong S.
    Mater Sci Eng C Mater Biol Appl; 2018 Aug 01; 89():316-327. PubMed ID: 29752103
    [Abstract] [Full Text] [Related]

  • 7. Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging.
    Ma Y, Zhou H, Hu F, Pei Z, Xu Y, Shuai Q.
    Artif Cells Nanomed Biotechnol; 2018 Aug 01; 46(sup3):S900-S910. PubMed ID: 30371105
    [Abstract] [Full Text] [Related]

  • 8. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma.
    Zhu D, Wu S, Hu C, Chen Z, Wang H, Fan F, Qin Y, Wang C, Sun H, Leng X, Kong D, Zhang L.
    Acta Biomater; 2017 Aug 01; 58():399-412. PubMed ID: 28627436
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A tumor-specific cleavable nanosystem of PEG-modified C60@Au hybrid aggregates for radio frequency-controlled release, hyperthermia, photodynamic therapy and X-ray imaging.
    Shi J, Chen Z, Wang L, Wang B, Xu L, Hou L, Zhang Z.
    Acta Biomater; 2016 Jan 01; 29():282-297. PubMed ID: 26485168
    [Abstract] [Full Text] [Related]

  • 11. Actively targeted delivery of anticancer drug to tumor cells by redox-responsive star-shaped micelles.
    Shi C, Guo X, Qu Q, Tang Z, Wang Y, Zhou S.
    Biomaterials; 2014 Oct 01; 35(30):8711-22. PubMed ID: 25002267
    [Abstract] [Full Text] [Related]

  • 12. A Multifunctional Lipid Incorporating Active Targeting and Dual-Control Release Capabilities for Precision Drug Delivery.
    Liu C, Ewert KK, Yao W, Wang N, Li Y, Safinya CR, Qiao W.
    ACS Appl Mater Interfaces; 2020 Jan 08; 12(1):70-85. PubMed ID: 31774266
    [Abstract] [Full Text] [Related]

  • 13. Disulfide cross-linked polyurethane micelles as a reduction-triggered drug delivery system for cancer therapy.
    Yu S, Ding J, He C, Cao Y, Xu W, Chen X.
    Adv Healthc Mater; 2014 May 08; 3(5):752-60. PubMed ID: 24574261
    [Abstract] [Full Text] [Related]

  • 14. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release.
    Pan YJ, Chen YY, Wang DR, Wei C, Guo J, Lu DR, Chu CC, Wang CC.
    Biomaterials; 2012 Sep 08; 33(27):6570-9. PubMed ID: 22704845
    [Abstract] [Full Text] [Related]

  • 15. Cyclodextrin based unimolecular micelles with targeting and biocleavable abilities as chemotherapeutic carrier to overcome drug resistance.
    Li W, Xu C, Li S, Chen X, Fan X, Hu Z, Wu YL, Li Z.
    Mater Sci Eng C Mater Biol Appl; 2019 Dec 08; 105():110047. PubMed ID: 31546452
    [Abstract] [Full Text] [Related]

  • 16. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity.
    Zhao S, Yu Q, Pan J, Zhou Y, Cao C, Ouyang JM, Liu J.
    Acta Biomater; 2017 May 08; 54():294-306. PubMed ID: 28267598
    [Abstract] [Full Text] [Related]

  • 17. Rod in Tube: A Novel Nanoplatform for Highly Effective Chemo-Photothermal Combination Therapy toward Breast Cancer.
    Zhang J, Luo X, Wu YP, Wu F, Li YF, He RR, Liu M.
    ACS Appl Mater Interfaces; 2019 Jan 30; 11(4):3690-3703. PubMed ID: 30618237
    [Abstract] [Full Text] [Related]

  • 18. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS, Singh RK, Kim TH, Kim JH, Patel KD, Kim HW.
    Acta Biomater; 2017 Jun 30; 55():466-480. PubMed ID: 28373086
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A, Salmaso S, Eldar-Boock A, Ben-Shushan D, Ferber S, Tiram G, Shmeeda H, Landa-Rouben N, Leor J, Caliceti P, Gabizon A, Satchi-Fainaro R.
    J Control Release; 2015 Jun 28; 208():106-20. PubMed ID: 25869964
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.